ST. PAUL, Minn. & PARIS--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced it will display a number of technologies from the company’s wide array of clinical solutions and launch its next-generation PressureWire™ Fractional Flow Reserve (FFR) assessment guidewire at EuroPCR 2012. There will also be a number of St. Jude Medical-sponsored percutaneous coronary intervention (PCI) optimization symposia and a late-breaking clinical trial session on the FAME II trial.
